SPCC965.10 Antibody

What is SPCC965.10 and why is it significant in fission yeast research?

SPCC965.10 is a protein encoded in Schizosaccharomyces pombe (strain 972/ATCC 24843), commonly known as fission yeast. This protein is part of the broader research landscape investigating protein functions in this model organism. S. pombe serves as an important model system for studying eukaryotic cellular processes due to its genetic tractability and relatively simple genome structure . Understanding SPCC965.10's function contributes to our knowledge of conserved cellular mechanisms that may have parallels in higher eukaryotes.

The significance of studying SPCC965.10 relates to broader research into protein function within the context of ubiquitin-dependent proteolysis systems in yeast. Similar F-box proteins like Pof1 have been shown to play essential roles in ubiquitin-dependent regulation of transcription factors like Zip1, which respond to environmental stressors such as cadmium . Research with SPCC965.10 antibodies enables investigation of protein expression, localization, and interactions to elucidate its cellular roles.

How should I validate the specificity of an SPCC965.10 antibody?

Proper validation of SPCC965.10 antibody specificity requires a multi-faceted approach:

• Western Blot Analysis: Compare the detection pattern between wild-type and knockout/knockdown strains. A specific antibody should show a band at the expected molecular weight in wild-type samples that is absent or significantly reduced in knockout/knockdown samples .

• Immunoprecipitation Controls: Perform parallel immunoprecipitations with both the specific antibody and an isotype control. Following the approach described in research with similar yeast proteins, precipitates should be analyzed by immunoblotting to confirm specificity .

• Peptide Competition Assay: Pre-incubate the antibody with excess purified SPCC965.10 peptide or protein before immunodetection. Specific binding should be blocked by this competition .

• Cross-Reactivity Testing: Test the antibody against closely related proteins or in other yeast species to assess potential cross-reactivity. This is especially important for conserved protein families .

• Immunofluorescence Comparison: Compare localization patterns with tagged versions of the protein (e.g., GFP-tagged SPCC965.10) to validate specificity of subcellular localization .

This multi-method validation approach follows standard practices in antibody research and ensures reliable experimental outcomes.

What are the recommended fixation and permeabilization protocols for immunofluorescence with SPCC965.10 antibody?

For optimal immunofluorescence results with SPCC965.10 antibody in S. pombe:

Fixation Protocol:

• Harvest cells during mid-log phase (OD600 0.5-0.8)

• Fix with 3-4% formaldehyde for 30 minutes at room temperature

• For membrane proteins, a methanol fixation (-20°C for 6 minutes) following formaldehyde can improve epitope accessibility

Permeabilization Protocol:

• Digest cell wall with Zymolyase (1 mg/ml) for 30-60 minutes at 37°C

• Permeabilize with 0.5% Triton X-100 for 5 minutes

Blocking and Antibody Incubation:

• Block with 3-5% BSA in PBS for 1 hour at room temperature

• Dilute primary antibody to optimal concentration (typically 1:100 to 1:500) and incubate overnight at 4°C

• Wash 3x with PBS-T (0.1% Tween-20)

• Incubate with fluorescently-labeled secondary antibody for 1-2 hours at room temperature

Similar protocols have been successfully used for immunodetection of yeast proteins like those in the SCF complex . Optimization of fixation time and antibody concentration may be necessary depending on the specific epitope recognized by the SPCC965.10 antibody.

How do post-translational modifications of target proteins affect SPCC965.10 antibody recognition?

Post-translational modifications (PTMs) can significantly impact antibody recognition and should be carefully considered when designing experiments. Based on studies of similar yeast proteins:

• Phosphorylation Effects: Phosphorylation can create multiple migration bands during SDS-PAGE, as observed with proteins like Zip1 in fission yeast. When working with potentially phosphorylated forms of SPCC965.10, treatment of immunoprecipitates with λ-phosphatase can help identify modified forms . The multiple migration bands may represent different phosphorylation states that could affect epitope accessibility.

• Ubiquitination Considerations: If SPCC965.10 is involved in ubiquitin-dependent processes (common in many yeast proteins), ubiquitination status may alter antibody recognition. Proteasome inhibitors like MG132 can be used to preserve ubiquitinated forms prior to immunoprecipitation .

• Experimental Strategy for PTM Assessment:

  • Compare antibody recognition in wild-type versus mutant strains defective in specific modifications

  • Use phosphatase or deubiquitinase treatments to remove PTMs before immunodetection

  • Compare detection patterns under different cellular stress conditions that might induce specific modifications

• Epitope-Specific Considerations: Antibodies recognizing regions near modification sites may show differential binding based on modification status. When possible, utilize antibodies targeting multiple epitopes to comprehensively detect all protein forms .

Understanding the PTM landscape of SPCC965.10 is crucial for accurate interpretation of experimental results, especially in signaling pathway research.

What are the best experimental designs for kinetic analysis of SPCC965.10 antibody-antigen interactions?

For rigorous kinetic analysis of SPCC965.10 antibody-antigen interactions, surface plasmon resonance (SPR) offers the most comprehensive approach. Based on established methodologies:

Experimental Design Recommendations:

• Surface Preparation:

  • Immobilize purified antibody using standard amine coupling chemistry

  • Create reference surfaces without antibody or with irrelevant antibody

  • Target immobilization levels between 500-2000 RU for optimal signal

• Antigen Concentration Series:

  • Prepare a concentration series spanning at least 10-fold below and above the expected KD

  • Use a minimum of 5-6 different concentrations for accurate fitting

  • Include duplicate runs for statistical validation

• Important Controls:

  • Buffer-only injections to establish baseline stability

  • Reference surface subtraction to eliminate matrix effects

  • Sample recovery analysis to validate binding models

• Data Analysis Approach:

  • Apply global fitting using numerical integration of differential rate equations

  • Test multiple binding models (1:1, two-state, heterogeneous ligand)

  • Combine fitting results with experimental evidence to discriminate between models

• Validation Experiments:

  • Vary injection duration to distinguish between different binding mechanisms

  • Perform dissociation experiments at different antigen concentrations

  • Recover and reanalyze bound antigen to assess potential conformational changes

As demonstrated in protein-protein interaction studies, experimental design is crucial for successful kinetic analysis. Multiple models may fit the same SPR data, so additional experiments are often needed to determine the true binding mechanism .

How can computational approaches predict SPCC965.10 antibody specificity and binding properties?

Recent advances in computational antibody engineering provide several approaches for predicting antibody specificity and optimizing binding properties:

• Sequence-Based Prediction Models:

  • Models like DyAb can predict binding affinities based on sequence information and limited training data

  • These approaches can identify beneficial mutations by calculating predicted affinity differences (ΔpKD) between variants

  • For new antibodies, sequence comparison with existing antibodies in databases like PLAbDab can provide initial specificity predictions

• Structure-Based Approaches:

  • When structural information is available, CDR structure analysis combined with sequence identity (>80%) provides the most accurate predictions of binding specificity

  • Heavy chain identity alone is insufficient; both heavy and light chain sequences should be considered for accurate specificity predictions

• Experimental Validation Strategy:

  • Top computational predictions should be experimentally validated using surface plasmon resonance (SPR)

  • Expression testing should be performed in parallel to ensure the designed variants are properly folded

  • Combined approaches using sequence, structure, and experimental feedback yield the most reliable results

• Database Utilization:

  • PLAbDab contains over 150,000 paired antibody sequences and can be searched by sequence identity, structural similarity, or keywords

  • For target-specific antibodies, database searches can identify similar antibodies with known specificity profiles

These computational approaches are particularly valuable when developing new antibodies or optimizing existing ones for improved specificity and affinity toward SPCC965.10.

What are the optimal immunoprecipitation protocols for SPCC965.10 antibody applications?

For successful immunoprecipitation of SPCC965.10 and associated complexes, the following optimized protocol is recommended:

Cell Preparation and Lysis:

• Harvest 50-100 ml of yeast culture at OD600 0.5-0.8

• Wash cells with cold PBS containing protease inhibitors

• Lyse cells using glass bead disruption in lysis buffer containing:

  • 50 mM HEPES, pH 7.5

  • 150 mM NaCl

  • 1 mM EDTA

  • 1% Triton X-100

  • Protease inhibitor cocktail

  • Phosphatase inhibitors (10 mM NaF, 2 mM Na3VO4)

• Clear lysate by centrifugation at 14,000g for 15 minutes at 4°C

Immunoprecipitation Procedure:

• Pre-clear lysate with 30 μl Protein G beads for 1 hour at 4°C

• Incubate 500-1000 μg of protein with 2-5 μg of SPCC965.10 antibody overnight at 4°C

• Add 30-50 μl Protein G beads and incubate for 2-3 hours at 4°C

• Wash beads 4-5 times with wash buffer (lysis buffer with reduced detergent concentration)

• Elute bound proteins with SDS sample buffer or use specific peptide elution for native conditions

Critical Considerations:

• If studying ubiquitinated forms, add 10 mM N-ethylmaleimide to all buffers

• For transient interactions, consider crosslinking with DSP (1 mM) before lysis

• For phosphorylation studies, include both protein phosphatase inhibitors and perform parallel samples with λ-phosphatase treatment to identify modified forms

This protocol has been adapted from successful approaches used for similar yeast proteins involved in protein-protein interactions and ubiquitin-mediated processes .

How should Western blot conditions be optimized for detection of low-abundance SPCC965.10?

Detection of low-abundance proteins like SPCC965.10 requires careful optimization of Western blot conditions:

Sample Preparation Optimization:

• Enrich the protein by subcellular fractionation if localization is known

• Use protease and phosphatase inhibitors during extraction

• Consider using protein precipitation methods (TCA/acetone) to concentrate samples

• Load higher protein amounts (50-100 μg) when detecting low-abundance proteins

Transfer and Detection Optimization:

• Transfer Parameters:

  • Use PVDF membranes (0.2 μm pore size) for better protein retention

  • Select wet transfer over semi-dry for more complete transfer of proteins

  • Transfer at lower voltage (30V) overnight at 4°C for improved efficiency

• Blocking Optimization:

  • Test different blocking agents (5% BSA often performs better than milk for phosphorylated proteins)

  • Reduce blocking time to 1 hour at room temperature

  • Include 0.05% Tween-20 in blocking solution to reduce background

• Antibody Incubation:

  • Incubate primary antibody (1:500-1:1000) overnight at 4°C

  • Use signal enhancers like HIKARI for Western blotting

  • Consider additional signal amplification systems for extremely low-abundance proteins

• Detection Strategy:

  • Use high-sensitivity ECL substrates for chemiluminescence detection

  • Optimize exposure times (multiple exposures from 30 seconds to 15 minutes)

  • Consider fluorescent secondary antibodies for better quantification of low signals

These optimizations have proven effective for detecting low-abundance proteins in yeast systems, including those involved in regulatory pathways similar to the potential functions of SPCC965.10 .

What techniques can effectively visualize SPCC965.10 dynamics during cell cycle progression?

To visualize SPCC965.10 dynamics throughout the cell cycle, a multi-technique approach is recommended:

Live-Cell Imaging Approach:

• Generate strains expressing SPCC965.10-GFP/RFP fusion proteins under native promoter control

• Implement time-lapse microscopy with temperature-controlled chambers for extended imaging

• Use nuclear markers (e.g., histone-mCherry) to correlate protein dynamics with cell cycle stages

• Analyze protein relocalization using quantitative image analysis software

Fixed-Cell Immunofluorescence Strategy:

• Synchronize cultures using:

  • Centrifugal elutriation to collect small G2 cells

  • Temperature-sensitive cdc mutants for specific cell cycle arrests

  • Hydroxyurea for S-phase arrest

• Fix cells at defined intervals after release from synchronization

• Process for immunofluorescence using optimized SPCC965.10 antibody protocols

• Counterstain with DAPI for nuclear visualization and cell cycle position assessment

Biochemical Analysis in Synchronized Populations:

• Collect samples at 20-30 minute intervals following synchronization

• Perform Western blotting to monitor total protein levels and modifications

• Conduct immunoprecipitation at different cell cycle stages to assess changing interaction partners

• Use phosphorylation-specific detection methods if SPCC965.10 is regulated by phosphorylation

Integration with Cell Cycle Markers:

• Include parallel detection of established cell cycle markers (Cdc2, cyclins)

• Monitor septum formation using calcofluor white staining

• Correlate SPCC965.10 changes with DNA content using flow cytometry

This comprehensive approach has proven effective for studying dynamic changes in regulatory proteins during the yeast cell cycle, particularly those involved in stress response pathways and transcriptional regulation .

How can contradictory SPCC965.10 antibody results be reconciled across different experimental conditions?

When faced with contradictory results using SPCC965.10 antibodies across different experimental conditions, a systematic troubleshooting approach is essential:

• Epitope Accessibility Analysis:

  • Different fixation methods may expose or mask epitopes

  • Denaturating versus native conditions can significantly affect antibody recognition

  • Test different sample preparation methods in parallel (e.g., various detergents, fixatives)

• Post-Translational Modification Effects:

  • Assess whether contradictory results correlate with different growth conditions that might alter PTM status

  • Compare results with and without phosphatase treatment

  • Consider the impact of stress conditions on protein modification patterns

• Antibody Validation Strategy:

  • Use multiple antibodies targeting different epitopes of SPCC965.10

  • Include tagged versions of the protein as positive controls

  • Perform rigorous specificity testing under each experimental condition

• Experimental Design to Resolve Contradictions:

  • Conduct side-by-side comparisons using standardized protocols

  • Implement quantitative analysis methods rather than qualitative assessments

  • Use genetic approaches (mutants, overexpression) to validate antibody-based observations

• Documentation and Reporting:

  • Thoroughly document all experimental conditions that produce variant results

  • Report the complete methodology, including buffer compositions and incubation times

  • Consider publishing contradictory results with appropriate controls to advance understanding

How can SPCC965.10 antibodies be used to investigate protein-protein interactions in stress response pathways?

SPCC965.10 antibodies can be powerful tools for investigating protein-protein interactions in stress response pathways, following methodologies established for similar yeast proteins:

Co-Immunoprecipitation Strategy:

• Subject yeast cultures to relevant stressors (e.g., oxidative stress, heavy metals, temperature shifts)

• Harvest cells at defined timepoints after stress induction

• Perform immunoprecipitation with SPCC965.10 antibody followed by mass spectrometry to identify stress-specific interaction partners

• Validate key interactions using reciprocal co-IP and targeted Western blotting

Proximity-Based Labeling Approach:

• Generate strains expressing SPCC965.10 fused to BioID or TurboID

• Induce proximity labeling under normal and stress conditions

• Purify biotinylated proteins and identify by mass spectrometry

• Compare interaction networks between conditions to identify stress-specific changes

Functional Validation Methods:

• Generate deletion or point mutation strains of identified interaction partners

• Assess the impact on SPCC965.10 localization, abundance, or modification status using the specific antibody

• Perform epistasis analysis to establish pathway relationships

• Use the antibody to monitor SPCC965.10 dynamics in various mutant backgrounds

In research with similar yeast proteins like Zip1 and Pof1, antibody-based approaches have been crucial for deciphering stress response pathways, particularly in the context of cadmium stress . The SCF complex interactions and their regulatory functions during stress provide a valuable model for investigating SPCC965.10's potential roles in similar processes.

What controls are essential when using SPCC965.10 antibody in chromatin immunoprecipitation (ChIP) experiments?

For reliable chromatin immunoprecipitation experiments using SPCC965.10 antibody, the following essential controls should be implemented:

Experimental Controls:

• Input Control:

  • Reserve 5-10% of sonicated chromatin before immunoprecipitation

  • Use for normalization and to confirm equal starting material across samples

• Negative Controls:

  • No-antibody control to assess non-specific binding to beads

  • IgG control using matched isotype antibody

  • Non-target gene regions (e.g., highly expressed housekeeping genes or silent heterochromatin regions)

• Positive Controls:

  • If known, include genomic regions previously established to bind SPCC965.10

  • Include ChIP for a well-characterized transcription factor or histone mark

• Biological Validation Controls:

  • Perform ChIP in deletion/knockdown strains to confirm antibody specificity

  • Use epitope-tagged SPCC965.10 and perform parallel ChIP with anti-tag antibody

  • Test multiple antibodies recognizing different epitopes of SPCC965.10

Technical Optimization Considerations:

• Crosslinking Optimization:

  • Test different formaldehyde concentrations (0.5-1.5%)

  • Optimize crosslinking time (10-20 minutes)

  • Consider dual crosslinking with additional agents for improved efficiency

• Sonication Parameters:

  • Optimize sonication to achieve chromatin fragments of 200-500 bp

  • Verify fragment size by agarose gel electrophoresis

  • Ensure consistent sonication across all samples

• Antibody Titration:

  • Perform ChIP with different antibody amounts to determine optimal concentration

  • Too little antibody results in weak signal; too much can increase background

• Washing Stringency:

  • Optimize salt concentrations in wash buffers

  • Adjust number of washes to balance between signal retention and background reduction

These controls and optimizations ensure that ChIP results accurately reflect the genomic binding profile of SPCC965.10 and minimize false positives from non-specific binding or technical artifacts.

How can SPCC965.10 antibodies be integrated with advanced imaging technologies for subcellular localization studies?

Integration of SPCC965.10 antibodies with advanced imaging technologies provides powerful approaches to study dynamic subcellular localization:

Super-Resolution Microscopy Applications:

• STORM/PALM Approaches:

  • Label SPCC965.10 antibodies with photoswitchable fluorophores

  • Achieve 20-30 nm resolution to precisely map protein localization

  • Combine with reference organelle markers for spatial context

  • Optimal fixation: 4% paraformaldehyde + 0.1% glutaraldehyde

• SIM Applications:

  • Less demanding sample preparation compared to STORM/PALM

  • Allows for multi-color imaging to simultaneously visualize interaction partners

  • Effective for capturing dynamic changes during stress responses

  • Compatible with standard immunofluorescence protocols

Live-Cell Advanced Imaging:

• Lattice Light-Sheet Microscopy:

  • Generate SPCC965.10-fluorescent protein fusions

  • Monitor rapid protein movements with minimal phototoxicity

  • Ideal for long-term imaging of protein dynamics during cell cycle progression

  • Can detect transient interactions with other cellular components

• FRET/FLIM Analysis:

  • Create donor-acceptor pairs with SPCC965.10 and potential interaction partners

  • Directly measure protein-protein interactions in living cells

  • Quantify interaction distances and affinities in different cellular compartments

Multi-Modal Imaging Strategy:

• Correlative Light and Electron Microscopy (CLEM):

  • Locate SPCC965.10 by fluorescence microscopy

  • Examine ultrastructural context using electron microscopy

  • Requires specialized fixation protocols and gold-conjugated secondary antibodies

  • Provides nanometer-scale resolution of protein localization

• Expansion Microscopy:

  • Physically expand samples to increase effective resolution

  • Compatible with standard SPCC965.10 antibody staining protocols

  • Achieves ~70 nm resolution with conventional microscopes

These advanced imaging approaches enable researchers to address sophisticated questions about SPCC965.10 localization, trafficking, and interactions that would be impossible with conventional microscopy alone.

What strategies can improve SPCC965.10 antibody design for enhanced specificity and reduced cross-reactivity?

Modern antibody engineering approaches offer several strategies to improve SPCC965.10 antibody specificity and reduce cross-reactivity:

Computational Design Approaches:

• ML-Based Sequence Optimization:

  • Models like DyAb can predict binding affinity changes based on sequence modifications

  • Start with existing antibodies and computationally identify mutations that enhance specificity

  • Focus on CDR regions, particularly CDR-H3, which contributes most to specificity

• Structure-Based Design:

  • When structural data is available, CDR structure analysis combined with sequence identity provides accurate specificity predictions

  • Optimize antibody sequences by modifying key residues that contact the target epitope

  • Consider both heavy and light chain contributions to specificity

Experimental Optimization Strategies:

• Negative Selection Approaches:

  • Incorporate depletion steps against close homologs of SPCC965.10

  • Perform counter-selection to remove antibodies that bind unwanted targets

  • Use phage display with alternating positive and negative selection rounds

• Epitope-Focused Design:

  • Target unique regions of SPCC965.10 that differ from homologous proteins

  • Use structural information to identify surface-exposed, unique epitopes

  • Consider bioinformatic analysis to identify minimally conserved regions

• Affinity Maturation:

  • Introduce targeted mutations in CDR regions

  • Test multiple variants for improved binding and reduced cross-reactivity

  • Select variants with optimal specificity profiles for further development

Validation and Testing:

• Comprehensive Cross-Reactivity Testing:

  • Test against panels of related proteins from S. pombe

  • Assess binding to homologs from other yeast species

  • Perform western blots with complex lysates from multiple organisms

• Epitope Binning:

  • Map the exact binding epitope using techniques like HDX-MS or peptide arrays

  • Group antibodies based on their epitope recognition profiles

  • Select antibodies targeting unique epitopes for maximum specificity

These approaches, combining computational prediction with experimental validation, provide powerful tools for developing next-generation SPCC965.10 antibodies with superior specificity profiles.

What are the key considerations for interpreting SPCC965.10 antibody data in the context of broader yeast biology?

Interpreting SPCC965.10 antibody data requires careful consideration of several contextual factors:

• Strain Background Effects:

  • Genetic background can significantly influence protein expression and localization

  • Always include wild-type controls matched to the strain background used

  • Consider testing in multiple strain backgrounds to establish generality of findings

• Growth Condition Dependencies:

  • Yeast protein expression and modification often varies with growth conditions

  • Document media composition, growth phase, and temperature in all experiments

  • Consider how environmental stressors might alter SPCC965.10 biology

• Cell Cycle Context:

  • Many yeast proteins show cell cycle-dependent regulation

  • When possible, synchronize cultures or use cell cycle markers to contextualize results

  • Consider whether contradictory results might reflect cell cycle-dependent changes

• Integration with -Omics Data:

  • Compare antibody-based observations with transcriptomics and proteomics datasets

  • Use global phosphoproteomics data to interpret potential phosphorylation states

  • Incorporate interaction data from high-throughput studies to build network models

• Evolutionary Context:

  • Consider conservation and divergence patterns when inferring functions

  • Compare with homologs in S. cerevisiae and other model systems

  • Use phylogenetic information to identify conserved functional domains

• Technical Limitations Awareness:

  • Recognize epitope-specific limitations of each antibody

  • Consider how sample preparation might affect protein detection

  • Acknowledge potential artifacts from overexpression or tagging approaches

By integrating these considerations, researchers can develop more robust interpretations of SPCC965.10 antibody data and place their findings within the broader context of yeast biology and conserved eukaryotic mechanisms.

How should researchers document and share SPCC965.10 antibody validation data to improve reproducibility?

To enhance reproducibility in SPCC965.10 antibody research, comprehensive documentation and sharing of validation data is essential:

Documentation Requirements:

• Antibody Specifications:

  • Complete source information (vendor, catalog number, lot number)

  • Host species, antibody class, and clonality (monoclonal/polyclonal)

  • Target epitope information when available

  • Storage conditions and handling recommendations

• Validation Data:

  • Western blot images showing specificity (including molecular weight markers)

  • Immunoprecipitation efficiency data

  • Cross-reactivity testing results against related proteins

  • Knockout/knockdown validation results

  • Comparison of different antibody lots if used across studies

• Experimental Protocols:

  • Detailed buffer compositions including pH and additives

  • Complete incubation times and temperatures

  • Sample preparation methods (lysis conditions, fixation protocols)

  • Image acquisition parameters for microscopy

  • Quantification methods and software used for analysis

Sharing Mechanisms:

• Publication Practices:

  • Include comprehensive validation data in supplementary materials

  • Deposit full-resolution images in public repositories

  • Consider publishing detailed protocols in journals like Bio-Protocol

• Community Resources:

  • Contribute validation data to antibody validation databases

  • Share detailed protocols through platforms like protocols.io

  • Deposit plasmids for tagged versions in repositories like Addgene

• Reproducibility Enhancements:

  • When possible, include multiple antibodies targeting different epitopes

  • Validate key findings using orthogonal approaches (e.g., mass spectrometry)

  • Consider pre-registration of experimental designs for critical studies